
Four members of the Antipodes investment team join this episode to discuss sector-specific outlooks for 2023. Sectors covered include:
Hardware, Industrials and Commodities
Healthcare
Domestic Asia and EM
Domestic Developed Markets.
This is our final episode for the year. We thank you all for listening and wish you a safe and happy holiday period. Remember to follow us on LinkedIn or Twitter to stay up to date with our insights.
Dec 20, 2022
31 min

In this episode, Alison Savas, talks with Antipodes Emerging Markets co-portfolio managers Sunny Bangia and John Stavliotis.
They discuss why investors should consider Emerging Markets now, along with some of the key opportunities across emerging economies - including Mexico, Indonesia and Brazil.
Dec 4, 2022
31 min

Escalating geopolitical tensions, Xi Jinping’s consolidation of power in China, and the US Fed’s economic ‘balancing act’ are some the most significant issues dominating the macroeconomic backdrop for global investors as we move into the final quarter of the calendar year.
In Part 1 (00:30) of this new podcast episode, Alison Savas and Sunny Bangia provide listeners an insight into the way Antipodes is approaching these global affairs and the anticipated consequences for investors.
In Part 2 (20:00), Alison and Sunny provide an update on Antipodes’ portfolio positioning and discuss portfolio holdings, Merck and Co (NYSE: MRK) and Diageo (LON: DGE).
Antipodes website: antipodes.com
Antipodes on Linkedin: Antipodes Partners
Nov 4, 2022
26 min

Through the recent decade-long bull market many have viewed short positions as simply a drag on performance. But in 2022 the regime has shifted. Portfolio protection has come back to the fore with the S&P 500 shedding around a quarter of its value so far this year, and concerns about global economic growth and central bank policy rising.
In this episode, Alison Savas and Jacob Mitchell discuss Antipodes’ approach to short selling and examine the case for Snap Inc. (NYSE: SNAP).
Oct 10, 2022
23 min

German energy giant, RWE, is faced with the challenge of helping to power a continent in the midst of a power crunch, while at the same time working towards ambitious decarbonisation targets.
In this episode, Alison Savas, talks to RWE's Chief Financial Officer, Michael Muller on the energy crisis, decarbonisation and RWE's operations.
Aug 26, 2022
28 min

In this quarterly market update episode Alison Savas and Antipodes CIO, Jacob Mitchell, discuss the state of equity markets in Q2 2022 and Antipodes bigger picture views on global investing and portfolio positioning.
Aug 2, 2022
28 min

Tech stocks have borne the brunt of the recent sell off in equity markets and with the Nasdaq firmly in bear market territory, it is unprofitable tech stocks that have been hit the hardest - down almost 60% this year.
But amid these sell offs, there can be category leaders that fall to attractive valuations, relative to their long-term growth profile. Antipodes thinks Seagate Technology (NASDAQ: STX) is one of those leaders, and it's priced at just 8x next year’s earnings.
In part one of this episode (2:20), Alison Savas speaks to Seagate's CFO, Gianluca Romano. In part two (22.00), Alison Savas and Graham Hay (Antipodes Portfolio Manager of Hardware, Industrials and Commodities) discuss the Seagate investment case.
Disclaimer:
All content in respect of the Antipodes Global Shares (Quoted Managed Fund) (ARSN 625 560 269), the Antipodes Global Fund – Long (ARSN 118 075 764), the Antipodes Global Fund (ARSN 087 719 515), and the Antipodes Asia Fund (ARSN 096 451 393) is issued by Pinnacle Fund Services Limited ABN 29 082 494 371 AFSL 238 371 (“PFSL”) as responsible entity of the Funds and is prepared by Antipodes Partners Limited (ABN 29 602 042 035) (AFSL 481580) (“Antipodes”) as the investment manager of the Trust. PFSL is not licensed to provide financial product advice.
The information provided is of a general nature only and has been prepared without taking into account your objectives, financial situation or needs. Before making an investment decision in respect of the Funds, you should consider the current product disclosure statement (PDS) and Target Market Determination (‘TMD’) of the Funds and the Fund’s other periodic and continuous disclosure announcements lodged with the ASX, which are available at www.asx.com.au, and assess whether the Fund is appropriate given your objectives, financial situation or needs. If you require advice that takes into account your personal circumstances, you should consult a licensed or authorised financial adviser.
Neither PFSL nor Antipodes guarantees repayment of capital or any particular rate of return from the Funds. Neither PFSL nor Antipodes gives any representation or warranty as to the currency, reliability, completeness or accuracy of the information contained in this content. All opinions and estimates included in this website constitute judgments of Antipodes as at the date of website creation and are subject to change without notice. Past performance is not a reliable indicator of future performance.
Jun 26, 2022
30 min

Alison Savas is joined by digital advertising expert Ben Legg to discuss the digital advertising landscape, in particular how Meta (NASDAQ: FB) is positioned following the recent fall in its stock price.
Key discussion points include:
4:00: Overview of how online advertise works today.
7:30: The digital advertising landscape and why digital advertising as a percentage of GDP is expected to grow.
10:50: The rise of Tik Tok
12:00: Meta's advertising technology and why it’s seen as being superior
21:10: How Facebook is moving to maintain user engagement
28.30: Can Instagram become the world’s biggest fashion retailer?
May 31, 2022
39 min

By the end of March, the S&P was only 5% shy of its all-time highs set in early January despite intensifying geopolitical and economic uncertainty. In fact, in early March US equities staged one of the largest and fastest bear market rallies since 1928. But the move back into the growthier tech complex in the US has now faded into April.
In this Q1 2022 market update, Alison Savas and Sunny Bangia discuss:
01:30: Why Stagflation has become Antipodes’ ‘base case’
04:40: The risk of Central Bank policy error
07:50: Antipodes’ portfolio positioning
10:30: Why Antipodes in holding the line on Chinese stocks
26:00: Antipodes’ China exposures
May 2, 2022
30 min

The war in Ukraine has seen the fragility of global energy and commodity markets laid bear. In this episode hear why Antipodes' investment team has been increasing exposure to energy and commodity stocks in recent years, the impact of sanctions on Russia and the longer-term outlook for the sectors.
In part two, hear a discussion about some of Antipodes' best investment ideas for exposure to longer-term energy and commodity trends.
Part 1 (1:00)
Why Antipodes' global portfolios have been overweight energy.
The impacts of the war in Ukraine on the energy and commodity sectors.
Decarbonisation and the longer-term outlook for energy and commodities.
Part 2 (14:30)
Technip Energies (EPA: TE) & Siemens Energy (ETR: ENR).
Nutrien (TSE: NTR).
Exposure to gold stocks - Newcrest Mining (ASX: NCM) & Barrick Gold (NYSE: GOLD).
For more investment insights visit antipodes.com
Mar 30, 2022
27 min
Load more
